“CVD patient journey 2020”: a global market research for and with patients affected by chronic venous diseases
In 2020, Servier, in collaboration with the Research Partnership agency, launched a global market study on the journey of patients suffering from chronic venous diseases (CVD). This research, whose objective was to better understand how patients feel in order to improve their care, has just delivered its results.
SPEAK UP!, a Servier podcast
Listen to Thibault Peudon, former Project Manager – Global Coordination & Business Intelligence
Conducted in five key representative countries (Brazil, China, Czech Republic, Italy and Russia), the research aimed to provide a complete understanding of the CVD patient journey, from both HCPs and patient perspectives, in particular by analyzing the impact of the disease on their emotions, attitudes, behavior and quality of life. Favoring a qualitative methodology, it was the subject of interviews with 100 patients and 60 specialists and one-week daily tasks for the patients.
Servier found that all patients recognized that CVD impact on their quality of life, to varying degrees depending on their profile. In addition to their unattractive appearance, often experienced as a burden, CVD have a significant impact on patients’ emotions and relationships: it increases their anxiety and fear, which affects their self-confidence and social life.
Another major lesson of this research is that the impact of CVD on quality of life seems to be neglected by physicians, who tend to focus solely on symptoms and overestimate the effect of venoactive drug and compression stockings.
Action levers to improve patient well-being
The data generated has enabled the identification of several levers for action to better support patients throughout their healthcare journey, such as:
- Improving the information provided as part of their treatment;
- More precisely measuring the impact of the new treatments developed on their quality of life;
- Raising awareness among healthcare professionals to better take into account the impact of CVD on the quality of life of their patients, in order to better adapt care to each profile.
For Bertrand Renaud, Chief Patient Officer at Servier:
“This project is a very good example of concrete and insights from patients suffering of chronic venous disease. This will help us to better answer to their needs, in particular to tailor our development to better take care of their quality of life. We thank them for their valuable participation.”